Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia.

Dresner E, Agam G, Gozes I.

Eur Neuropsychopharmacol. 2011 May;21(5):355-61. doi: 10.1016/j.euroneuro.2010.06.004. Epub 2010 Jul 3.

PMID:
20598862
2.

Silencing of the ADNP-family member, ADNP2, results in changes in cellular viability under oxidative stress.

Kushnir M, Dresner E, Mandel S, Gozes I.

J Neurochem. 2008 Apr;105(2):537-45. doi: 10.1111/j.1471-4159.2007.05173.x. Epub 2007 Dec 19.

3.

Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate.

Gozes I.

Peptides. 2011 Feb;32(2):428-31. doi: 10.1016/j.peptides.2010.10.030. Epub 2010 Nov 2. Review.

PMID:
21050875
4.

Novel evolutionary-conserved role for the activity-dependent neuroprotective protein (ADNP) family that is important for erythropoiesis.

Dresner E, Malishkevich A, Arviv C, Leibman Barak S, Alon S, Ofir R, Gothilf Y, Gozes I.

J Biol Chem. 2012 Nov 23;287(48):40173-85. doi: 10.1074/jbc.M112.387027. Epub 2012 Oct 15.

5.

Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.

Giladi E, Hill JM, Dresner E, Stack CM, Gozes I.

J Mol Neurosci. 2007;33(3):278-83. Epub 2007 Oct 2.

PMID:
17952637
6.

Brain injury-dependent expression of activity-dependent neuroprotective protein.

Zaltzman R, Alexandrovich A, Beni SM, Trembovler V, Shohami E, Gozes I.

J Mol Neurosci. 2004;24(2):181-7.

PMID:
15456931
7.

ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance.

Mandel S, Spivak-Pohis I, Gozes I.

J Mol Neurosci. 2008 Jun;35(2):127-41. doi: 10.1007/s12031-007-9013-y. Epub 2008 Feb 20.

PMID:
18286385
8.

Activity-dependent neuroprotective protein (ADNP) expression in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease.

Fernandez-Montesinos R, Torres M, Baglietto-Vargas D, Gutierrez A, Gozes I, Vitorica J, Pozo D.

J Mol Neurosci. 2010 May;41(1):114-20. doi: 10.1007/s12031-009-9300-x. Epub 2009 Oct 21.

PMID:
19844808
10.

New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.

Merenlender-Wagner A, Shemer Z, Touloumi O, Lagoudaki R, Giladi E, Andrieux A, Grigoriadis NC, Gozes I.

Autophagy. 2014;10(12):2324-32. doi: 10.4161/15548627.2014.984274.

11.

ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment.

Malishkevich A, Leyk J, Goldbaum O, Richter-Landsberg C, Gozes I.

J Mol Neurosci. 2015 Oct;57(2):304-13. doi: 10.1007/s12031-015-0640-4.

PMID:
26315608
12.

The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome.

Poggi SH, Goodwin K, Hill JM, Brenneman DE, Tendi E, Schinelli S, Abebe D, Spong CY.

Am J Obstet Gynecol. 2003 Sep;189(3):790-3.

PMID:
14526315
13.

Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus.

Furman S, Hill JM, Vulih I, Zaltzman R, Hauser JM, Brenneman DE, Gozes I.

Neurosci Lett. 2005 Jan 3;373(1):73-8.

PMID:
15555780
14.

Autophagy has a key role in the pathophysiology of schizophrenia.

Merenlender-Wagner A, Malishkevich A, Shemer Z, Udawela M, Gibbons A, Scarr E, Dean B, Levine J, Agam G, Gozes I.

Mol Psychiatry. 2015 Feb;20(1):126-32. doi: 10.1038/mp.2013.174. Epub 2013 Dec 24.

15.
16.

Pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) co-localizes with activity-dependent neuroprotective protein (ADNP) in the mouse brains.

Nakamachi T, Ohtaki H, Yofu S, Dohi K, Watanabe J, Hayashi D, Matsuno R, Nonaka N, Itabashi K, Shioda S.

Regul Pept. 2008 Jan 10;145(1-3):88-95. Epub 2007 Sep 25.

PMID:
17942168
17.

Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment.

Urigüen L, García-Fuster MJ, Callado LF, Morentin B, La Harpe R, Casadó V, Lluis C, Franco R, García-Sevilla JA, Meana JJ.

Psychopharmacology (Berl). 2009 Oct;206(2):313-24. doi: 10.1007/s00213-009-1608-2. Epub 2009 Aug 4.

PMID:
19652957
18.

Activity-dependent neuroprotective protein: from gene to drug candidate.

Gozes I.

Pharmacol Ther. 2007 May;114(2):146-54. Epub 2007 Feb 1. Review.

PMID:
17363064
19.
20.

Differential expression of embryonic and maternal activity-dependent neuroprotective protein during mouse development.

Poggi SH, Vink J, Goodwin K, Hill JM, Brenneman DE, Pinhasov A, Gozes I, Spong CY.

Am J Obstet Gynecol. 2002 Oct;187(4):973-6.

PMID:
12388989

Supplemental Content

Support Center